Camouflage Therapy for Post-Inflammatory Hyperpigmentation on the Face Caused by Fixed Drug Eruption

Tomoko Kayama, Hiroko Fujii, Miki Tanioka, Yoshiki Miyachi

Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

DOI: 10.4236/jcdsa.2013.33A2003                

Abstract

Camouflage therapy has been used for permanent contour and pigmentary defects including telangiectasias, vitiligo, lentigines, nevi, atrophic scars and burn scars. The goal of the therapy is to provide new and innovative ways to normalize the appearance of patients with abnormalities. A variety of cosmetic techniques are used to assist these patients in making their irregularities as inconspicuous as possible. Post-inflammatory hyperpigmentation is a frustrating problem afflicting many dermatology patients, particularly on the face. Here we report a case of successful cosmetic camouflage using the theory of complementary colors of light in a patient with post-inflammatory hyperpigmentation of the face caused by fixed drug eruption. Our case report supports the idea that camouflage for patients with post-inflammatory hyperpigmentation on the face caused by fixed drug eruption improves their quality of life and also supports the idea that camouflage should be part of the after care for patients who have received patch testing.

Keywords

Cosmetic Camouflage; Post-Inflammatory Hyperpigmentation; Complementary Colors

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	C. Antoniou and C. Stefanaki, “Cosmetic Camouflage,” Journal of Cosmetic Dermatology, Vol. 5, No. 4, 2006, pp. 297-301. http://dx.doi.org/10.1111/j.1473-2165.2006.00274.x
[2]	M. Tanioka and Y. Miyachi, “Camouflage for Vitiligo,” Dermatologic Therapy, Vol. 22, No. 1, 2009, pp. 90-93. http://dx.doi.org/10.1111/j.1529-8019.2008.01220.x
[3]	B. Hell, F. Frangillo-Engler, E. Heissler, et al., “Camouflage in Head and Neck Region—A Non-Invasive Option for Skin Lesions,” International Journal of Oral and Maxillofacial Surgery, Vol. 28, No. 2, 1999, pp. 90-94. http://dx.doi.org/10.1016/S0901-5027(99)80199-4
[4]	Y. Morita, T. Kondo, A. Iijima and K. Usuda, “Covering Foundation Improves Quality of Life in Patients with Melasma,” Skin Research, Vol. 8, No. 4, 2009, pp. 435- 439.
[5]	M. Tanioka, Y. Yamamoto, M. Kato and Y. Miyachi, “Camouflage for Patients with Vitiligo Vulgaris Improved Their Quality of Life,” Journal of Cosmetic Dermatology, Vol. 9, No. 1, 2010, pp. 72-75. http://dx.doi.org/10.1111/j.1473-2165.2010.00479.x
[6]	V. D. Callender, S. St Surin-Lord, E. C. Davis and M. Maclin, “Postinflammatory Hyperpigmentation: Etiologic and Therapeutic Considerations,” American Journal of Clinical Dermatology, Vol. 12, No. 2, 2011, pp. 87-99. http://dx.doi.org/10.2165/11536930-000000000-00000
[7]	Z. K. Draelos, “Cosmetics in the Postsurgical Patient,” Dermatologic Clinics, Vol. 13, No. 2, 1995, pp. 461-465.